Search Results - "Liontos, Michalis"

Refine Results
  1. 1
  2. 2

    The emerging role of capivasertib in breast cancer by Andrikopoulou, Angeliki, Chatzinikolaou, Spyridoula, Panourgias, Evangelia, Kaparelou, Maria, Liontos, Michalis, Dimopoulos, Meletios-Athanasios, Zagouri, Flora

    Published in Breast (Edinburgh) (01-06-2022)
    “…Over 50% of breast tumors harbor alterations in one or more genes of the phosphatidylinositol 3-kinase (PI3K) pathway including PIK3CA mutations (31%), PTEN…”
    Get full text
    Journal Article
  3. 3

    Advances in Gynecological Cancers by Liontos, Michalis, Fiste, Oraianthi, Zagouri, Flora, Dimopoulos, Meletios-Athanasios

    “…The burden of gynecological cancer constitutes a major focus of public health efforts, as it continues to represent a significant cause of cancer mortality,…”
    Get full text
    Journal Article
  4. 4

    The emerging role of BET inhibitors in breast cancer by Andrikopoulou, Angeliki, Liontos, Michalis, Koutsoukos, Konstantinos, Dimopoulos, Meletios-Athanasios, Zagouri, Flora

    Published in Breast (Edinburgh) (01-10-2020)
    “…Bromodomain and extraterminal domain (BET) proteins are epigenetic molecules that regulate the expression of multiple genes involved in carcinogenesis. Breast…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Clinical perspectives of BET inhibition in ovarian cancer by Andrikopoulou, Angeliki, Liontos, Michalis, Koutsoukos, Konstantinos, Dimopoulos, Meletios-Athanasios, Zagouri, Flora

    Published in Cellular oncology (Dordrecht) (01-04-2021)
    “…Background Bromodomain and extra-terminal (BET) proteins are epigenetic readers that bind to acetylated lysines of histones and regulate gene transcription…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Angiogenesis-related pathways in the pathogenesis of ovarian cancer by Gavalas, Nikos G, Liontos, Michalis, Trachana, Sofia-Paraskevi, Bagratuni, Tina, Arapinis, Calliope, Liacos, Christine, Dimopoulos, Meletios A, Bamias, Aristotle

    “…Ovarian Cancer represents the most fatal type of gynecological malignancies. A number of processes are involved in the pathogenesis of ovarian cancer,…”
    Get full text
    Journal Article Book Review
  12. 12
  13. 13

    Factors contributing to inappropriate ordering of tests in an academic medical department and the effect of an educational feedback strategy by Miyakis, Spiros, Karamanof, Georgios, Liontos, Michalis, Mountokalakis, Theodore D

    Published in Postgraduate medical journal (01-12-2006)
    “…Aims: To identify factors contributing to laboratory overutilisation in an academic medical department, and to assess the effect of an educational feedback…”
    Get full text
    Journal Article
  14. 14

    The Impact of Positive Peritoneal Cytology on the Survival Rates of Early-Stage-Disease Endometrial Cancer Patients: Systematic Review and Meta-Analysis by Pergialiotis, Vasilios, Panagiotopoulos, Michail, Koutras, Antonios, Daras, Andreas, Ntounis, Thomas, Liontos, Michalis, Daskalakis, Georgios, Thomakos, Nikolaos

    Published in Medicina (Kaunas, Lithuania) (01-05-2024)
    “…The impact of positive peritoneal cytology has been a matter of controversy in early-stage endometrial cancer for several years. The latest staging systems do…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review by Andrikopoulou, Angeliki, Fiste, Oraianthi, Liontos, Michalis, Dimopoulos, Meletios-Athanasios, Zagouri, Flora

    Published in Cancers (26-01-2021)
    “…Treatment with aromatase inhibitors (AIs) is fundamental in women with hormone receptor-positive breast cancer in the adjuvant as well as the metastatic…”
    Get full text
    Journal Article
  17. 17

    The Mutational Landscape of Early-Onset Breast Cancer: A Next-Generation Sequencing Analysis by Andrikopoulou, Angeliki, Chatzinikolaou, Spyridoula, Kyriopoulos, Ilias, Bletsa, Garyfalia, Kaparelou, Maria, Liontos, Michalis, Dimopoulos, Meletios-Athanasios, Zagouri, Flora

    Published in Frontiers in oncology (21-01-2022)
    “…Around 5%-7% of breast cancer cases are diagnosed in women younger than 40, making it the leading cause of female cancer in the 25- to 39-year-old age group…”
    Get full text
    Journal Article
  18. 18

    Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis by Andrikopoulou, Angeliki, Zografos, Eleni, Apostolidou, Kleoniki, Kyriazoglou, Anastasios, Papatheodoridi, Alksistis-Maria, Kaparelou, Maria, Koutsoukos, Konstantinos, Liontos, Michalis, Dimopoulos, Meletios-Athanasios, Zagouri, Flora

    Published in Frontiers in oncology (01-12-2022)
    “…Germline BRCA1/2 mutations are identified in 13-15% of ovarian cancers, while an additional 5-7% of ovarian cancers harbor somatic BRCA1/2 mutations. Beyond…”
    Get full text
    Journal Article
  19. 19
  20. 20